Share Capital - Schedule of Warrants Outstanding (Details) - $ / shares		6 Months Ended
		Jun. 30, 2020	Dec. 31, 2019
Series A (2013) [Member]
Number of outstanding warrants	[1]	183	183
Exercise price	[1]	$ 2,754.00
Number of exercisable warrants	[1]	183
Exercisable Through	[1]	April 9, 2023
Series A (2015) [Member]
Number of outstanding warrants	[1]		683
Exercise price	[1]	$ 1,377.00
Number of exercisable warrants	[1]
Exercisable Through	[1]	April 30, 2020
Series B (2016) [Member]
Number of outstanding warrants	[1]	2,770	2,770
Exercise price	[1]	$ 40.50
Number of exercisable warrants	[1]	2,770
Exercisable Through	[1]	March 14, 2022
Warrant to Underwriters 1/2019 [Member]
Number of outstanding warrants		22,767	22,767
Exercise price		$ 8.13
Number of exercisable warrants		22,767
Exercisable Through		July 14, 2022
Warrant to Underwriters 1/2019 One [Member]
Number of outstanding warrants		29,500	29,500
Exercise price		$ 12.50
Number of exercisable warrants		29,500
Exercisable Through		July 15, 2022
Warrant to Underwriters 1/2019 Two [Member]
Number of outstanding warrants			12,500
Exercise price		$ 12.50
Number of exercisable warrants		12,500
Exercisable Through		January 15, 2020
Warrant to Underwriters 12/2019 [Member]
Number of outstanding warrants		45,643	45,643
Exercise price		$ 13.13
Number of exercisable warrants
Exercisable Through		June 27, 2023
Warrant to Underwriters 12/2019 One [Member]
Number of outstanding warrants		47,619	47,619
Exercise price		$ 13.13
Number of exercisable warrants
Exercisable Through		June 30, 2023
Warrant to Underwriters 12/2019 Two [Member]
Number of outstanding warrants		45,045	45,045
Exercise price		$ 13.88
Number of exercisable warrants
Exercisable Through		June 25, 2023

[1] Prior to January 1, 2019, warrants with non-standard anti-dilution provisions (referred to as down round protection) were classified as liabilities and re-measured each reporting period. On January 1, 2019, the Company adopted the provisions of ASU 2017-11, which indicates that a down round feature no longer precludes equity classification when assessing whether an investment is indexed to an entity's own stock. The Company used a full retrospective approach to adoption and restated its financial statements as of the earliest period presented. The cumulative effect of adoption of ASU 2017-11 resulted in an adjustment to accumulated deficit as of January 1, 2018 of $20 with a corresponding adjustment to additional paid-in capital.